Glipizide And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 70518-0373

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide And Metformin Hydrochloride (NDC 70518-0373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Glipizide and Metformin Hydrochloride 5 mg/500 mg film-coated tablets. The package quantity is 90 tablets. The label shows the product is prescription only (RX ONLY) with NDC 70518-0373-00. Manufactured by Teva Pharma, North Wales, PA, and repackaged by RemedyRepack Inc., Indiana, PA. Includes storage instructions and barcode details.*

FDA Label Image

Image 1

Chemical structure diagram showing the molecular structure of Glipizide and Metformin Hydrochloride combined.*

FDA Label Image

Image 2

Chemical structure of Glipizide and Metformin Hydrochloride showing the molecular arrangement including the metformin component with the hydrochloride group (HCl) depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.